M.H. Haloua

ORCID: 0000-0002-5583-9781
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer survivorship and care
  • Peripheral Nerve Disorders
  • Cancer Treatment and Pharmacology
  • Diagnosis and Treatment of Venous Diseases
  • Medical and Biological Sciences
  • Advances in Oncology and Radiotherapy
  • Wound Healing and Treatments
  • Cancer Diagnosis and Treatment
  • Reconstructive Surgery and Microvascular Techniques

OLVG
2018

Amsterdam UMC Location VUmc
2011-2018

Ziekenhuis Gelderse Vallei
2016

Medisch Centrum Alkmaar
2012

Academic Medical Center
2011

Gelre Hospitals
2011

Purpose. Over recent decades, no consensus has yet been reached on the optimal approach to cosmetic evaluation following breast-conserving therapy (BCT). The present study compared strengths and weaknesses of BCCT.core software with a 10-member panel from various backgrounds. Methods. Digital photographs 109 consecutive patients after BCT were evaluated for 7 items by consisting 2 breast surgeons, residents, laypersons, 4 plastic surgeons. All objectively using (version 20), an overall...

10.1155/2014/716860 article EN cc-by International Journal of Breast Cancer 2014-01-01

Ultrasound-guided breast-conserving surgery (USS) results in a significant reduction both margin involvement and excision volumes (COBALT trial). The aim of the present study was to determine whether USS also leads improvements cosmetic outcome patient satisfaction when compared with standard palpation-guided (PGS). A total 134 patients T1–T2 invasive breast cancer were included COBALT trial (NTR2579) randomized either (65 patients) or PGS (69 patients). Cosmetic outcomes assessed by...

10.1245/s10434-015-4906-4 article EN cc-by Annals of Surgical Oncology 2015-10-20

Introduction Cosmetic results and quality of life (QoL) are increasingly important in the treatment breast cancer. This study was designed to determine relationship between QoL both subjectively objectively measured cosmetic outcomes breast‐conserving therapy (BCT), its course over time. Methods A total 128 cancer patients who underwent BCT as part a prospective randomized controlled trial were included. using EORTC QLQ‐C30 QLQ‐BR23 at baseline, 3, 6, 12, 36 months. outcome determined by...

10.1002/jso.24615 article EN Journal of Surgical Oncology 2017-03-23

Background and Objectives To identify breast‐specific factors the role of tumor, treatment, patient‐related items in influencing patient opinion on cosmesis satisfaction after breast‐conserving therapy (BCT). Methods Data from randomized COBALT study was used. At 3, 12, 36 months, 128 patients with T1‐T2 breast cancer completed a questionnaire overall cosmetic outcome satisfaction, using 4‐point Likert scale. Results There strong positive correlation between factors, outcome,and at all...

10.1002/jso.25012 article EN Journal of Surgical Oncology 2018-02-23

Ultrasound-guided surgery (USS) has recently been proven to result in a significant reduction of tumour-involved surgical margins, for patients with palpable invasive breast cancer. The objective this economic evaluation alongside randomised trial was evaluate the costs and benefits USS compared palpation-guided (PGS). hospital perspective used. On cost side analysis, resource use related baseline treatment taken into account on benefit side, additional treatments included. difference per...

10.1016/j.breast.2013.02.002 article EN cc-by-nc-nd The Breast 2013-03-09

Abstract Background: Breast-conserving surgery for palpable breast cancer is worldwide associated with a high rate of tumour-involved margins and excessive healthy tissue resection. This results in additional treatment poor cosmetic outcome. Ultrasound-guided (USS) may resolve both problems by improving surgical accuracy. A randomised controlled trial was initiated to compare USS the standard palpation-guided (PGS) cancer. Methods: total 134 eligible patients T1-T2 invasive were either (n =...

10.1158/0008-5472.sabcs12-pd04-01 article EN Cancer Research 2012-12-01
Coming Soon ...